ImmuPharma PLC New Phase III Lupuzor Trial Data Positive – May 2018
31st May 2018 - 3:11 pmChairman Tim McCarthy talks to DirectorsTalk about the further analysis of the results from its pivotal Phase III trial of Lupuzor and final results.
Chairman Tim McCarthy talks to DirectorsTalk about the further analysis of the results from its pivotal Phase III trial of Lupuzor and final results.